Publications of I. A. Nakchbandi

Nakchbandi, I. A.: Commentary on Grey et al. (2011): Does methadone maintenance therapy adversely affect bone mass? Addiction 106 (2), pp. 355 - 356 (2011)

von Au, A.; Vasel, M.; Cecchini, M.; Nakchbandi, I. A.: The role of fibronectin originating from different sources on breast cancer metastasis development and bone remodeling. Bone 48 (1 Sp. Iss.), p. S50 - S50 (2011)

Gramoun, A.; Azizi, N.; Sodek, J.; Heersche, J. N. M.; Nakchbandi, I.; Manolson, M. F.: Fibronectin Inhibits Osteoclastogenesis While Enhancing Osteoclast Activity via Nitric Oxide and Interleukin-1 beta-Mediated Signaling Pathways. Journal of Cellular Biochemistry 111 (4), pp. 1020 - 1034 (2010)

Hackl, N.; von Au, A.; Vasel, M.; Tiwari, S.; Cecchini, M. G.; Nakchbandi, I. A.: The role of fibronectin in the bone marrow metastatic niches. Bone 47 (Suppl. 2), pp. S263 - S264 (2010)

Bentmann, A.; Kawelke, N.; Moss, D.; Zentgraf, H.; Bala, Y.; Berger, I.; Gasser, J. A.; Nakchbandi, I. A.: Circulating Fibronectin Affects Bone Matrix, Whereas Osteoblast Fibronectin Modulates Osteoblast Function. Journal of Bone and Mineral Research 25 (4), pp. 706 - 715 (2010)

Hackl, N. J.; Bersch, C.; Feick, P.; Antoni, C.; Franke, A.; Singer, M. V.; Nakchbandi, I. A.: Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C. Scandinavian Journal of Gastroenterology 45 (3), pp. 349 - 356 (2010)

Nakchbandi, I. A.; van der Merwe, S. W.: Current understanding of osteoporosis associated with liver disease. Nature Reviews Gastroenterology & Hepatology 6 (11), pp. 660 - 670 (2009)

Bentmann, A.; Kawelke, N.; Moss, D.; Nakchbandi, I.: Circulating Fibronectin Affects Bone Matrix. Journal of Bone and Mineral Research 23 (Suppl. Suppl. S), p. S163 - S163 (2008)

Nakchbandi, W.; Muller, H.; Singer, M. V.; Lohr, J. M.; Nakchbandi, I. A.: Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma. Journal of Gastrointestinal and Liver Diseases 17 (3), pp. 285 - 290 (2008)

Phillips, J. A.; Almeida, E. A. C.; Hill, E. L.; Aguirre, J. I.; Rivera, M. F.; Nachbandi, I.; Wronski, T. J.; van der Meulen, M. C. H.; Globus, R. K.: Role for beta 1 integrins in cortical osteocytes during acute musculoskeletal disuse. Matrix Biology 27 (7), pp. 609 - 618 (2008)

Kawelke, N.; Bentmann, A.; Hackl, N.; Hager, H. D.; Feick, P.; Geursen, A.; Singer, M. V.; Nakchbandi, I. A.: Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. Journal of Bone and Mineral Research 23 (8), pp. 1278 - 1286 (2008)

Nakchbandi, I. A.; Lohr, J. M.: Coagulation, anticoagulation and pancreatic carcinoma. Nature Clinical Practice Gastroenterology & Hepatology 5 (8), pp. 445 - 455 (2008)

Mormann, M.; Thederan, M.; Nackchbandi, I.; Giese, T.; Wagner, C.; Hansch, G. M.: Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: A link between infection and pathological bone resorption. Molecular Immunology 45 (12), pp. 3330 - 3337 (2008)

Nakchbandi, I. A.; Lang, R.; Kinder, B.; Insogna, K. L.: The role of the receptor activator of nuclear factor-kappa B ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. Journal of Clinical Endocrinology & Metabolism 93 (3), pp. 967 - 973 (2008)

Bentmann, A.; Kawelke, N.; Gasser, J.; Nakchbandi, I. A.: Circulating plasma fibronectin is needed for a normal bone density. Calcified Tissue International 82 (Suppl. Suppl. 1), p. S97 - S97 (2008)

Bentmann, A.; Kawelke, N.; Moss, D.; Nakchbandi, I. A.: Osteoblast fibronectin affects their behavior in vivo. Calcified Tissue International 82 (Suppl. Suppl. 1), p. S97 - S97 (2008)

Kawelke, N.; Bentmann, A.; Hackl, N.; Nakchbandi, I. A.: Bone loss in patients with primary biliary cirrhosis is caused by a fibronectin isoform. Calcified Tissue International 82 (Suppl. Suppl. 1), p. S106 - S106 (2008)

Nakchbandi, W.; Muller, H.; Singer, M. V.; Lohr, M.; Nakchbandi, I. A.: Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma. Scandinavian Journal of Gastroenterology 41 (9), pp. 1095 - 1104 (2006)

Aszodi, A.; Legate, K. R.; Nakchbandi, I.; Fässler, R.: What mouse mutants teach us about extracellular matrix function. Ann. Rev. Cell Dev. Biol. 22, pp. 591 - 621 (2006)

Altrock, E.; Sottile, J.; Nakchbandi, I. A.: INHBITION OF MATRIX ACCUMULATION USING SMALL PEPTIDES REVERSES LIVER FIRBOSIS. In Journal of Hepatology, 64, p. S706 - S706. EASL International Liver Congress, Barcelona, SPAIN, April 13, 2016 - April 17, 2016. Elsevier, Amsterdam (2016)